DYN

Dyne Therapeutics (DYN)

Dyne Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:DYN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/02/03	21:30	GlobeNewswire Inc.	Dyne Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference	NASDAQ:DYN	Dyne Therapeutics Inc
2025/01/21	21:30	GlobeNewswire Inc.	Dyne Therapeutics Receives FDA Fast Track Designation for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1	NASDAQ:DYN	Dyne Therapeutics Inc
2025/01/10	20:56	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DYN	Dyne Therapeutics Inc
2025/01/10	20:30	GlobeNewswire Inc.	Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potential Submission for U.S. Accelerated Approval for DYNE-101	NASDAQ:DYN	Dyne Therapeutics Inc
2025/01/09	21:30	GlobeNewswire Inc.	Dyne Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:DYN	Dyne Therapeutics Inc
2025/01/09	06:05	GlobeNewswire Inc.	Dyne Therapeutics to Host Investor Conference Call and Webcast to Review New Clinical Data from the ACHIEVE Trial Friday, January 10 at 8:00 a.m. ET	NASDAQ:DYN	Dyne Therapeutics Inc
2024/12/12	10:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/12/12	06:19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/12/11	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/12/07	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/12/07	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/12/07	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/12/05	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/11/26	06:11	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/11/23	06:06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/11/19	09:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/11/19	06:40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/11/19	06:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/11/19	06:13	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/11/19	06:06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/11/19	06:05	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/11/16	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/11/15	06:59	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/11/14	23:27	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:DYN	Dyne Therapeutics Inc
2024/11/14	21:00	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:DYN	Dyne Therapeutics Inc
2024/11/12	23:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DYN	Dyne Therapeutics Inc
2024/11/12	21:35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DYN	Dyne Therapeutics Inc
2024/11/12	21:30	GlobeNewswire Inc.	Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:DYN	Dyne Therapeutics Inc
2024/11/09	07:31	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:DYN	Dyne Therapeutics Inc
2024/11/08	06:15	GlobeNewswire Inc.	Dyne Therapeutics to Present at Upcoming Investor Conferences	NASDAQ:DYN	Dyne Therapeutics Inc